Clinical Trials Logo

Valvular Insufficiency clinical trials

View clinical trials related to Valvular Insufficiency.

Filter by:
  • None
  • Page 1

NCT ID: NCT04509479 Completed - Clinical trials for Valvular Heart Disease

National Tunisian Registry of Valvulopathies (NATURE-VALVE)

NATURE-VALVE
Start date: July 6, 2020
Phase:
Study type: Observational [Patient Registry]

The National Tunisian Registry of Valvulopathies is an observational, prospective and multicenter study aiming to assess the epidemiological, clinical and therapeutic profile of valve disease in tunisian departments of cardiology. Cardiologists from both sectors (public and private) are participating in the study, with 37 investigational centers. Data will be captured electronically by DACIMA Clinical Suite, according to FDA 21 CFR part 11 (Food and Drug Administration 21 Code of Federal Regulations part 11), HIPAA (Health Insurance Portability and Accountability Act) & ICH (International Conference on Harmonisation) requirements.

NCT ID: NCT03793296 Withdrawn - Clinical trials for Heart Valve Diseases

Percutaneous Device Closure for Significant Paravalvular Leakage After Transcatheter or Surgical Valve Replacement

PVL closure
Start date: January 31, 2019
Phase: N/A
Study type: Interventional

This study evaluates the effectiveness and safety of Percutaneous Device Closure for Significant Paravalvular Leakage after transcatheter or surgical valve replacement.

NCT ID: NCT00819377 Completed - Clinical trials for Coronary Artery Disease

Milrinone Inhaled in Cardiac Surgery

Start date: February 2009
Phase: Phase 2
Study type: Interventional

Pulmonary hypertension is an important morbidity factor in patients having to undergo cardiac surgery with cardiopulmonary bypass (ECC). Milrinone used in inhalation, shows evidence of being a pulmonary vasodilator able to possibly contribute to the reduction of pressure on the pulmonary artery.